After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Spyre Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Spyre Therapeutics Inc is $1.82B. A total of 0.61 million shares were traded on the day, compared to an average of 825.58K shares.
In the most recent transaction, Turtle Cameron sold 45,000 shares of SYRE for 23.33 per share on Nov 03 ’25. After the transaction, the Chief Executive Officer now owns 701,907 company shares. In a previous transaction on Nov 03 ’25, CAMERON TURTLE bought 90,000 shares at 24.46 per share.
Among the insiders who sold shares, Burrows Scott L disposed of 18,428 shares on Sep 02 ’25 at a per-share price of $16.26. This resulted in the Chief Financial Officer holding 97,994 shares of SYRE after the transaction.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SYRE has a high of $40.26 and a low of $10.91.
As of this writing, SYRE has an earnings estimate of -$0.73 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$1.31. The company reported an EPS of -$0.81 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SYRE’s latest balance sheet shows that the firm has $93.13M in Cash & Short Term Investments as of fiscal 2021. There were $5.06M in debt and $20.14M in liabilities at the time. Its Book Value Per Share was $7.48, while its Total Shareholder’s Equity was $83.94M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SYRE is Buy with a score of 4.73.
